Unknown

Dataset Information

0

Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound.

ABSTRACT: For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducibly make new, high quality, molecules with potential for biological activity. This article reports the successful achievement of this goal. Using previously rehearsed alkylating agents, students in a second semester organic chemistry laboratory performed a solid-phase combinatorial chemistry experiment in which they made 38 new analogs of the most potent member of a class of antimelanoma compounds. All compounds were made in duplicate, purified by silica gel chromatography, and characterized by NMR and LC/MS. As a continuing part of the Distributed Drug Discovery program, a virtual D(3) catalog based on this work was then enumerated and is made freely available to the global scientific community.

SUBMITTER: Scott WL 

PROVIDER: S-EPMC2651688 | biostudies-literature | 2009 Jan-Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound.

Scott William L WL   Audu Christopher O CO   Dage Jeffery L JL   Goodwin Lawrence A LA   Martynow Jacek G JG   Platt Laura K LK   Smith Judith G JG   Strong Andrew T AT   Wickizer Kirk K   Woerly Eric M EM   O'Donnell Martin J MJ  

Journal of combinatorial chemistry 20090101 1

For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducibly make new, high quality, molecules with potential for biological activity. This article reports the successful achievement of this goal. Using previously rehearsed alkylating agents, students in a second semester organic chemistry laboratory performed a solid-phase combinatorial chemistry experime  ...[more]

Similar Datasets

Unknown Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery.
| S-EPMC10879537 | biostudies-literature
Unknown Hexosamine analogs: from metabolic glycoengineering to drug discovery.
| S-EPMC3038843 | biostudies-literature
Unknown Drug repurposing: Discovery of troxipide analogs as potent antitumor agents.
| S-EPMC7319647 | biostudies-literature
Unknown Discovery of Survivin Inhibitors Part 1: Screening the Harbor Branch Pure Compound Library.
| S-EPMC7911841 | biostudies-literature
Unknown The human Aurora kinase inhibitor danusertib is a lead compound for anti-trypanosomal drug discovery via target repurposing.
| S-EPMC3516633 | biostudies-literature
Unknown Discovery of Retro-1 Analogs Exhibiting Enhanced Anti-vaccinia Virus Activity.
| S-EPMC7190985 | biostudies-literature
Unknown Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.
| S-EPMC2651687 | biostudies-literature
Unknown A Novel Methodology to Synthesize Highly Conductive Anion Exchange Membranes.
| S-EPMC4550832 | biostudies-literature
Unknown High throughput screening for anti-Trypanosoma cruzi drug discovery.
| S-EPMC4256210 | biostudies-other
Unknown Discovery, synthesis, and biological evaluation of piperidinol analogs with anti-tuberculosis activity.
| S-EPMC2756498 | biostudies-literature